June, 2024

We’re proud to announce that our recent work on enhancing robot-assisted surgery has been featured as a Featured Article in the prestigious IEEE Transactions on Biomedical Engineering journal (Link). Our research addresses a critical challenge in robotic surgery: the inability to perform manual palpation to detect pathological tissues like tumors. To overcome this challenge, we developed a robotic palpation device capable of rapidly and non-invasively quantifying the stiffness of soft tissues. This innovation allows surgeons to make data-driven decisions during minimally invasive procedures, significantly improving patient outcomes.

January, 2024

Bullseye Biodevices, Inc. was offically founded in January 2024 with a mission to advancing medical technology. From our inception, we’ve been dedicated to developing innovative solutions that enhance surgical precision and improve patient outcomes.

November, 2024

We’re thrilled to share that our groundbreaking discoveries from the NY Regional I-Corps and NSF National I-Corps programs have been highlighted on the NY I-Corps Hub website. (Link)

August, 2023

We had the honor of presenting our work at the I-Corps Annual Meeting, where we delivered a lightning presentation. This opportunity allowed us to showcase our innovative solutions and connect with leaders in the industry, further advancing our mission in medical technology.

May, 2023

We embarked on a transformative Customer Discovery Journey by participating in the NSF I-Corps program. This experience allowed us to deeply engage with potential users, such as surgeons and hospital stakeholders, gather invaluable feedback, and refine our approach based on real-world insights. The journey was pivotal in shaping our understanding of customer needs and enhancing our product development strategy.

April, 2023

Our team participated in the Business Plan Competition at the Tissue Engineering and Regenerative Medicine (TERMIS 2023) conference. This event provided us with a platform to present our innovative solutions to a panel of experts and industry leaders. The competition was a valuable opportunity to showcase our vision, gain feedback, and network with key stakeholders in the field of tissue engineering and regenerative medicine.